Lingzi Hong

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Cancer Stem Cells

Radiation Therapy

Top Venues

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lingzi Hong, Tomasz Herjan, Xing Chen, Leah L Zagore, Katarzyna Bulek, Han Wang, Chi-Fu Jeffrey Yang, Donny D Licatalosi, Xiaoxia Li, Xiao Li
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis. The Journal of experimental medicine 221 (7) (2024)
Lingzi Hong, Tomasz Herjan, Xing Chen, Leah L Zagore, Katarzyna Bulek, Han Wang, Chi-Fu Jeffrey Yang, Donny D Licatalosi, Xiaoxia Li, Xiao Li
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis. The Journal of experimental medicine 221 (7) (2024)
Lingzi Hong, Tomasz Herjan, Xing Chen, Leah L Zagore, Katarzyna Bulek, Han Wang, Chi-Fu Jeffrey Yang, Donny D Licatalosi, Xiaoxia Li, Xiao Li
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis. The Journal of experimental medicine 221 (7) (2024)
Lingzi Hong, Tomasz Herjan, Xing Chen, Leah L Zagore, Katarzyna Bulek, Han Wang, Chi-Fu Jeffrey Yang, Donny D Licatalosi, Xiaoxia Li, Xiao Li
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis. The Journal of experimental medicine 221 (7) (2024)
Xing Chen, Junjie Zhao, Tomasz Herjan, Lingzi Hong, Yun Liao, Caini Liu, Kommireddy Vasu, Han Wang, Austin Thompson, Paul L Fox, Brian R Gastman, Xiao Li, Xiaoxia Li
IL-17-induced HIF1α drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion. The Journal of experimental medicine 219 (6) (2022)